CIK: 0001502287 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 13, 2025
Total Value ($000): $114,362 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MONEYLION, INC. | 622,931 | $53,578 | 46.8% | $12.01 | — | CL A | 60938K304 |
| PATH | UIPATH, INC. | 1,286,527 | $16,352 | 14.3% | $60.06 | -78.0% | CL A | 90364P105 |
| TRDA | ENTRADA THERAPEUTICS, INC. | 761,277 | $13,162 | 11.5% | $16.89 | — | COM | 29384C108 |
| DKNG | DRAFTKINGS INC | 321,804 | $11,971 | 10.5% | $36.12 | +9.9% | COM CL A | 26142V105 |
| OKUR | ONKURE THERAPEUTICS INC | 491,938 | $4,231 | 3.7% | $15.14 | 0.0% | COM CL A | 68277Q105 |
| — | NEUEHEALTH INC. | 525,247 | $3,897 | 3.4% | $12.22 | — | COM NEW | 10920V404 |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | 422,085 | $3,427 | 3.0% | $33.23 | -62.7% | COM | 71722W107 |
| COIN | COINBASE GLOBAL INC | 13,281 | $3,298 | 2.9% | $253.86 | 0.0% | COM CL A | 19260Q107 |
| — | HILLEVAX, INC. | 826,569 | $1,711 | 1.5% | $11.39 | — | COM | 43157M102 |
| — | SENTINELONE INC | 35,326 | $784 | 0.7% | $22.20 | — | CL A | 8173OH109 |
| — | VACASA, INC. | 147,261 | $722 | 0.6% | $6.82 | — | CL A NEW | 91854V206 |
| TNYA | TENAYA THERAPEUTICS, INC. | 462,163 | $661 | 0.6% | $21.49 | -89.6% | COM | 87990A106 |
| GROV | GROVE COLLABORATIVE HOLDINGS, INC. | 380,383 | $529 | 0.5% | $2.20 | -37.4% | COM CL A | 39957D201 |
| METC | RAMACO RES INC | 3,787 | $39 | 0.0% | $11.21 | 0.0% | COM CL A | 75134P600 |